2020
DOI: 10.1053/j.semtcvs.2019.12.004
|View full text |Cite
|
Sign up to set email alerts
|

A Prospective Randomized Blinded Trial of Remote Ischemic Preconditioning in Children Undergoing Cardiac Surgery

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

2
13
0
1

Year Published

2021
2021
2024
2024

Publication Types

Select...
6
2

Relationship

0
8

Authors

Journals

citations
Cited by 12 publications
(16 citation statements)
references
References 37 publications
2
13
0
1
Order By: Relevance
“…Cheung et al first demonstrated reductions in troponin release and perioperative inotropic requirements with RIPC in a heterogeneous cohort of 37 children, most of whom had either TOF or VSD, a similar population to our trial [7]. Several small studies found improved myocardial protection, with reduced early troponin release in infants and young children undergoing VSD closure [8,9], whilst others found no benefit in neonates or infants undergoing other operations for congenital heart disease [10][11][12]15]. In the largest paediatric trial of RIPC to date, McCrindle et al found no benefit in clinical outcomes, physiological biomarkers, or subgroup analyses in a mixed cohort of 299 children aged 0-17 years in Toronto, Canada [13] and proposed that better than expected outcomes in the control group, heterogeneity of underlying conditions, and use of propofol may have affected their findings.…”
Section: Discussionsupporting
confidence: 62%
See 2 more Smart Citations
“…Cheung et al first demonstrated reductions in troponin release and perioperative inotropic requirements with RIPC in a heterogeneous cohort of 37 children, most of whom had either TOF or VSD, a similar population to our trial [7]. Several small studies found improved myocardial protection, with reduced early troponin release in infants and young children undergoing VSD closure [8,9], whilst others found no benefit in neonates or infants undergoing other operations for congenital heart disease [10][11][12]15]. In the largest paediatric trial of RIPC to date, McCrindle et al found no benefit in clinical outcomes, physiological biomarkers, or subgroup analyses in a mixed cohort of 299 children aged 0-17 years in Toronto, Canada [13] and proposed that better than expected outcomes in the control group, heterogeneity of underlying conditions, and use of propofol may have affected their findings.…”
Section: Discussionsupporting
confidence: 62%
“…The promise of this simple, low-risk, inexpensive and readily available intervention as an adjunct to current methods for myocardial protection during cardiac surgery has prompted numerous trials in adults [26][27][28][29][30][31] and children [7][8][9][10][11][12][13][14][15] but with mixed results. A meta-analysis suggested that RIPC reduces myocardial injury during cardiac surgery [32], but subsequently two large multi-centre trials in adults failed to show benefit in either composite cardiovascular endpoints or troponin release [30,31]; both were criticised for using propofol anaesthesia after it had been shown to interfere with the preconditioning pathway [16,17].…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Figure 1 is a flow diagram of the study and summarizes the process of trial selection. Thirteen eligible RCTs were identified that had enrolled 1,352 children randomly assigned to either RIPreC or control groups [ 17 29 ]. The main characteristics and methodological quality of these trials are summarized in Table 1 and Fig.…”
Section: Resultsmentioning
confidence: 99%
“…4b). The serum IL-6 level at 24 hours after surgery was reported in 13 trials, 4,9,12,21,22,34,36,38,55,56,62,64,65 which did not show statistical signi cance (SMD − 0.4, 95% CI -0.9 to 0.1, I 2 = 93%) (Fig. 4b).…”
Section: Effect Of Ripc On In Ammatory Cytokine Levelsmentioning
confidence: 90%